Budget Impact and Incremental Survival Benefit of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Brazil.

U. Majethia,G. Tremblay,L. Borges,T. Jones,A. Forsythe,D. Pomerantz,O. Clark
DOI: https://doi.org/10.1016/j.jval.2014.08.2211
IF: 5.156
2014-11-01
Value in Health
Abstract:
What problem does this paper attempt to address?